Please login to the form below

Not currently logged in
Email:
Password:

RSV

This page shows the latest RSV news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 2 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    The previous licensing deal was for exclusive global rights to the phase 1‐ready RSV compound, AK0529 which is now in a phase 2 study.

  • Deal Watch table for September 2014 Deal Watch table for September 2014

    Company acquisition. Anti-viral therapies, lead compound AL-8176 an oral antiviral in phase II for infant RSV.

  • Pharma deals during September 2014 Pharma deals during September 2014

    Alios has an oral anti-viral in phase 2 for treatment of infant respiratory syncytial virus (RSV) which complements J&J's early stage programmes in RSV.

  • Deal Watch table for June 2013 Deal Watch table for June 2013

    175. MicroDose Therapeutx / Teva. Acquisition. Acquisition of inhalation technology including MDT-637 for RSV (phase II).

  • Pharma deals during June 2013 Pharma deals during June 2013

    The deal brings to Teva a multi dose dry powder nebuliser technology and MDT-637, a low dose, small molecule, fusion inhibitor for the treatment of respiratory syncytial virus (RSV).

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Dutch biotech Mucosis promotes Thomas Johnston to CEO Dutch biotech Mucosis promotes Thomas Johnston to CEO

    development and commercialisation of the Mimopath platform including our RSV vaccine candidate.". ... During the last 12 months Mucosis has completed a clinical proof of concept study in human influenza for Mimopath and advanced respiratory syncytial

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
"Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....

Infographics